Cofactor Genomics YC 지원서

Summer 2015Active

Cofactor Genomics은(는) Summer 2015 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Summer 2015
산업: HealthcareDiagnostics
팀 규모: 13
상태: Active
출시됨: 2015

창업자

Dave MessinaFounder/COO
Jarret GlasscockFounder/CTO

Cofactor Genomics의 사업 내용

Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes. Led by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. The team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. After a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. Current investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).

Cofactor Genomics의 YC 지원서, 재구성됨

Y Combinator 지원

Cofactor Genomics, Summer 2015 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Cofactor Genomics

Describe what your company does in 50 characters or less.

Cofactor closes the precision medicine gap with predictive diagnostics

What is your company going to make? Please describe your product and what it does or will do.

We build diagnostic tests using RNA sequencing and predictive immune modeling to create biomarkers that better predict patient responses, mainly for cancer immunotherapy. Our product helps doctors select which patients will respond to specific treatments, improving outcomes where current diagnostics fall short.

Where do you live now, and where would the company be based after YC?

We live and work in St. Louis, Missouri, and the company remains based there.

Explain your decision regarding location.

St. Louis grounds us with access to strong genomics talent and a supportive healthcare ecosystem, including relationships with national healthcare systems. We don't see a need to relocate right now.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

Cofactor Genomics의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Cofactor Genomics의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Cofactor Genomics과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.